MannKind Corporation (NASDAQ: MNKD) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has received a milestone payment, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The milestone payment; what we’re seeing from MNKD stock … Read more
Durect Corp. (NASDAQ:DRRX) On Monday, Durect Corp stock fell by 32% after Pain Therapeutics (PTIE) received a Complete Response Letter — CRL — from the Food and Drug Administration — FDA. The drug that received the CRL is known as Remoxy ER, and was Pain’s drug obtained through a license from Durect Corp. The FDA … Read more
Amgen, Inc. (NASDAQ:AMGN) On October 28, 2015 Amgen had announced that it had received FDA approval for its skin cancer drug known as IMLYGIC. This drug is an injection type drug that helps boost the immune system to fight off and kill cancerous skin cells. This therapy only treats Melanoma — skin cancer– but does … Read more
Regulus Therapeutics (NASDAQ:RGLS) & AstraZeneca (NYSE:AZN) On April 7, 2015 Shares of Regulus were up about 8% in after hours trading after the company reported that Astrazeneca would like to collaborate with the company to develop a NASH drug. NASH stands for non-alcoholic steatohepatitis and as the name suggests it is a disease that doesn’t … Read more